Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia

BACKGROUND: Thrombocytopenia, characterized by a diminished platelet count, emerged as the most frequently reported coagulation dysfunction event according to the FDA Adverse Event Reporting System (FAERS) database. In recent years, numerous clinical studies have investigated the potential link betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yuanchao, Zhao, Fei, Jin, Pengfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508280/
https://www.ncbi.nlm.nih.gov/pubmed/37732172
http://dx.doi.org/10.2147/IDR.S426259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508280/
https://www.ncbi.nlm.nih.gov/pubmed/37732172
http://dx.doi.org/10.2147/IDR.S426259

Ejemplares similares